Medical Health & Life Science Research News

US anticoagulation therapy market projected to reach USD 27.83 billion by 2022

US anticoagulation therapy market projected to reach USD 27.83 billion by 2022

The growth in the US anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs).

- Agency -.

US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. Market is segmented into products (anticoagulation drugs & PT/INR testing devices) & anticoagulation clinics.

In addition, growth of anticoagulation clinics market is primarily driven by increasing prevalence of cardiovascular diseases & blood disorders, high level of medication adherence associated with clinics, & rising aging population.

Get sample copy of this research at

www.rnrmarketresearch.com/contacts…ple?rname=1237630 .

- Agency -.

In this report, the US anticoagulation therapy market is segmented on the basis of products and clinics. On the basis of products, the market is segmented into anticoagulation drugs and PT/INR testing devices.

Based on drug type, the anticoagulation therapy market for drugs is segmented into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment dominated the US anticoagulation therapy market for drugs.

Target Audience:

  • Healthcare service providers
  • Healthcare service payers/insurance payers
  • Pharmaceutical companies
  • Medical device companies
  • Venture capitalists
  • Government bodies
  • Business research and consulting firms

The anticoagulation therapy market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. The in-office devices segment dominated the US anticoagulation therapy market for PT/INR testing devices.

The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services.

Complete report on US Anticoagulation Therapy Market spread across 86 Pages, Profiling 6 Companies and Supported with 29 Tables and 25 Figures is now available at www.rnrmarketresearch.com/us-antic…arket-report.html .

The anticoagulation therapy market for drugs is categorized into NOACs, war far in (VKA), and other drugs. The NOACs segment is expected to grow at the highest CAGR during the forecast period.

Due to the better safety and efficacy of NOACs, as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs.

Research report categorizes US anticoagulation therapy market into following segments:

  • US Anticoagulation Therapy (Products) Market
  • US Anticoagulation Therapy (Products) Market For PT/INR Testing Devices
  • US Anticoagulation Therapy Market For Clinics

Market players such as C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

Access report @ www.rnrmarketresearch.com/contacts…ase?rname=1237630 .

Key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC - Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics. Consequently, many other companies are also expected to focus on developing more safe and efficient NOACs in the coming years; this will ensure the continued growth of this segment.

Research Coverage:

The US anticoagulation therapy market in this report is segmented by products and clinics. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, and industry-specific opportunities).

The study tracks and analyzes competitive developments (such as new product developments and R&D activities) and profiles the key players in the US anticoagulation therapy market.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.